Gastrointestinal Stromal Tumors: A Focus on Diagnosis and Management

Ahmed M. Kabel^{1, 2,} , Ahad D. Alofi³, Aisha H. Almalki³, Asrar A. Al Qurashi³ and Maha S. Al Ghamdi³

¹Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, KSA

²Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt

³Final year student, College of Pharmacy, Taif University, Taif, KSA

Cite this paper:
Ahmed M. Kabel, Ahad D. Alofi, Aisha H. Almalki, Asrar A. Al Qurashi and Maha S. Al Ghamdi. Gastrointestinal Stromal Tumors: A Focus on Diagnosis and Management. Journal of Cancer Research and Treatment. 2017; 5(2):68-72. doi: 10.12691/jcrt-5-2-5

Abstract

Gastrointestinal stromal tumors (GISTs) are rare tumors of the gastrointestinal (GI) tract that usually start in very early forms of special cells found in the wall of the GI tract, called the interstitial cells of Cajal (ICCs). Symptoms are usually variable, depending on tumor size and location, but many patients are asymptomatic. Most gastrointestinal stromal tumors (GISTs) occur in the stomach or small intestine. These tumors might not cause any symptoms unless they are in a certain location or grow to a certain size. Small tumors might not cause any symptoms and may be found accidentally when the physician is looking for another problem. These tumors are often benign. The main treatment for GIST that hasn’t spread is usually surgery to remove all of the tumors. The above mentioned topics, as well as classification, causes, clinical presentation, diagnosis and prognosis of GISTs were discussed in this review.

Keywords:
gastrointestinal stroma tumor diagnosis management

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Rammohan A, Sathyanesan J, Rajendran K, Pitchaimuthu A, Perumal SK, Srinivasan U, et al. A gist of gastrointestinal stromal tumors: A review. World J Gastrointest Oncol. 2013; 5(6): 102-12.
[2]	Iorio N, Sawaya RA, Friedenberg FK. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours. Aliment Pharmacol Ther. 2014; 39(12): 1376-86.
[3]	Adwas AA, Elkhoely AA, Kabel AM, Abdel-Rahman MN, Eissa AA (2016). Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice. J Infect Chemother. 22(1): 36-43.
[4]	Al-Shboul OA. The Importance of Interstitial Cells of Cajal in the Gastrointestinal Tract. Saudi J Gastroenterol. 2013; 19(1): 3-15.
[5]	Koumarianou A, Economopoulou P, Katsaounis P, et al. Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment Concepts. Biomarkers in Cancer. 2015; 7 (Suppl 1): 1-7.
[6]	Zhao X, Yue C. Gastrointestinal stromal tumor. J Gastrointest Oncol. 2012; 3(3): 189-208.
[7]	Dinc T, Kayilioglu SI, Erdogan A, Cetinkaya E, Akgul O, Coskun F. Small Intestinal and Mesenteric Multiple Gastrointestinal Stromal Tumors Causing Occult Bleeding. Case Rep Gastrointest Med. 2016 (2016): 5137975.
[8]	Yanagimoto Y, Takahashi T, Muguruma K, Toyokawa T, Kusanagi H, Omori T, et al. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy. Gastric Cancer. 2015; 18(2): 426-33.
[9]	Cameron S, Beham A, Schildhaus HU. Current Standard and Future Perspectives in the Treatment of Gastrointestinal Stromal Tumors. Digestion. 2017; 95(4): 262-8.
[10]	Vale Rodrigues R, Santos F, Pereira da Silva J, FranciscoI, Claro I, Albuquerque C, et al. A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro). Fam Cancer. 2017; 16 (2): 267-70.
[11]	Calibasi G, Baskin Y, Alyuruk H, Cavas L, Oztop I, Sagol O, et al. Molecular analysis of the KIT gene in gastrointestinal stromal tumors with novel mutations. Appl Immunohistochem Mol Morphol. 2014; 22(1): 37-45.
[12]	Nilsson B, Bümming P, Meis‐Kindblom JM, Odén A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. Cancer. 2005; 103(4): 821-9.
[13]	Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, et al. Gastrointestinal stromal tumor. World J Surg Oncol. 2009; 7(1): 1.
[14]	Goettsch WG, Bos SD, Breekveldt-Postma N, et al. Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study. Eur J Cancer 2005; 41: 2868-72.
[15]	Bamboat ZM, DeMatteo RP. Updates on the management of Gastrointestinal Stromal Tumors (GIST). Surg Oncol Clin of N Am. 2012; 21(2): 301-16.
[16]	Eisenberg BL, Pipas JM. Gastrointestinal stromal tumor--background, pathology, treatment. Hematol Oncol Clin North Am. 2012; 26(6): 1239-59.
[17]	Gong J, Kang W, Zhu J, Xu J. CT and MR imaging of gastrointestinal stromal tumor of stomach: a pictorial review. Quant Imaging Med Surg. 2012; 2(4): 274-9.
[18]	Tirumani SH, Baheti AD, Tirumani H, O’Neill A, Jagannathan JP. Update on Gastrointestinal Stromal Tumors for Radiologists. Korean J Radiol. 2017; 18(1): 84-93.
[19]	Williams A, Gutzeit A, Germer M, Pless M. PET-Negative Gastrointestinal Stromal Tumors. Case Rep Oncol. 2013; 6(3): 508-13.
[20]	Nishida T. The Role of Endoscopy in the Diagnosis of Gastric Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2015; 22(9): 2810-11.
[21]	Nannini M, Astolfi A, Urbini M, Biasco G, Pantaleo MA. Liquid biopsy in gastrointestinal stromal tumors: a novel approach. J Transl Med. 2014; 12: 210.
[22]	Liu Y, Zhang H-L, Zhang Y, et al. Digestive tract hemorrhage due to complications with gastrointestinal stromal tumor treated with sunitinib: A case report. Oncol Lett. 2013; 5(2): 699-701.
[23]	Bhatnagar SN. Gastrointestinal stromal tumor: Role of surgery and immunotherapy. J Indian Assoc Pediatr Surg. 2010; 15(4): 148-50.
[24]	Cao G, Li J, Shen L, Zhu X. Transcatheter arterial chemoembolization for gastrointestinal stromal tumors with liver metastases. World J Gastroenterol. 2012; 18(42): 6134-40.
[25]	Yamanaka T, Takaki H, Nakatsuka A, Uraki J, Fujimori M, Hasegawa T, et al. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor. J Vasc Interv Radiol. 2013; 24(3): 341-6.
[26]	Koo HJ, Shin JH, Shin S, Yoon HK, Ko GY, Gwon DI. Efficacy and Clinical Outcomes of Transcatheter Arterial Embolization for Gastrointestinal Bleeding from Gastrointestinal Stromal Tumor. J Vasc Interv Radiol. 2015; 26(9):1297-304.e1.
[27]	Linch M, Claus J, Benson C. Update on imatinib for gastrointestinal stromal tumors: duration of treatment. Onco Targets Ther. 2013;6: 1011-23.
[28]	Lamba G, Gupta R, Lee B, Ambrale S, Liu D. Current management and prognostic features for gastrointestinal stromal tumor (GIST). Exp Hematol Oncol. 2012; 1: 14.
[29]	Kabel AM, Abd Elmaaboud MA. Cancer: Role of Nutrition, Pathogenesis, Diagnosis and Management. World Journal of Nutrition and Health 2014; 2(4): 48-51.
[30]	Gatto L, Nannini M, Saponara M, et al. Radiotherapy in the management of gist: state of the art and new potential scenarios. Clinical Sarcoma Research. 2017; 7: 1.
[31]	Liu Z, Tian Y, Liu S, et al. Clinicopathological feature and prognosis of primary hepatic gastrointestinal stromal tumor. Cancer Medicine. 2016; 5(9): 2268-75.
[32]	Feng F, Tian Y, Liu Z, Liu S, Xu G, Guo M, Lian X, Fan D, Zhang H. Clinicopathological features and prognosis of omental gastrointestinal stromal tumor: evaluation of a pooled case series. Sci Rep. 2016; 6:30748.
[33]	Vadakara J, von Mehren M. Gastrointestinal Stromal Tumors: Management of metastatic disease and emerging therapies. Hematol Oncol Clin North Am. 2013; 27(5): 905-20.